Literature DB >> 1521514

Clinical manifestations of acromegaly.

M E Molitch1.   

Abstract

Acromegaly is an uncommon disorder and may present in a variety of ways, leading to considerable delay in diagnosis. Unlike other pituitary tumors, tumors associated with acromegaly tend to be fairly large in most patients. Thus, symptoms may be commonly due to the tumor mass as well as to hormone oversecretion. Mortality is two- to threefold increased due to cardiovascular, respiratory, and neoplastic causes. An increase in diabetes mellitus and hypertension may contribute to the first of these. Early treatment may reverse the diabetes, soft tissue changes, sleep apnea, cardiovascular disease, and neuromuscular disease. The effect of early treatment on neoplasia is unclear, and patients probably should continue to be screened, especially for colon neoplasia, even after appropriate therapy for the acromegaly. Hypopituitarism may be present initially as a result of tumor mass but may also develop as a result of ablative therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521514

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  33 in total

Review 1.  Treatment options in acromegaly. Benefits and costs.

Authors:  L M Weekes; K K Ho; J P Seale
Journal:  Pharmacoeconomics       Date:  1996-11       Impact factor: 4.981

Review 2.  Acromegaly.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Endocrinol Metab Clin North Am       Date:  2008-03       Impact factor: 4.741

3.  Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry.

Authors:  Christof Schöfl; David Petroff; Anke Tönjes; Martin Grussendorf; Michael Droste; Günter Stalla; Cornelia Jaursch-Hancke; Sylvère Störmann; Jochen Schopohl
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

Review 4.  Medical management of growth hormone-secreting pituitary adenomas.

Authors:  Michael S Racine; Ariel L Barkan
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

5.  What the mind knows but the eyes may still miss: reducing the 'Acromegalic Window'.

Authors:  Parijat De; Danielle R G Foucault
Journal:  BMJ Case Rep       Date:  2014-05-26

6.  Twenty-four hour profile of blood pressure in patients with acromegaly. Correlation with demographic, clinical and hormonal features.

Authors:  M Terzolo; C Matrella; A Boccuzzi; S Luceri; M Borriero; G Reimondo; A Pia; E Rovero; P Paccotti; A Angeli
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

Review 7.  Dermatologic manifestations of endocrine disorders.

Authors:  Michael Lause; Alisha Kamboj; Esteban Fernandez Faith
Journal:  Transl Pediatr       Date:  2017-10

Review 8.  Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults.

Authors:  A Giustina; A Barkan; P Chanson; A Grossman; A Hoffman; E Ghigo; F Casanueva; A Colao; S Lamberts; M Sheppard; S Melmed
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

9.  Gender-related differences in growth hormone-releasing pituitary adenomas. A clinicopathological study.

Authors:  Bernhard Schaller
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 10.  Acromegaly pathogenesis and treatment.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2009-11-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.